GLENN LEVINE to Fibrinolytic Agents
This is a "connection" page, showing publications GLENN LEVINE has written about Fibrinolytic Agents.
Connection Strength
0.787
-
Newer pharmacotherapy in patients undergoing percutaneous coronary interventions: a guide for pharmacists and other health care professionals. Pharmacotherapy. 2006 Nov; 26(11):1537-56.
Score: 0.236
-
Antithrombotic therapy in patients with acute coronary syndromes. Arch Intern Med. 2001 Apr 09; 161(7):937-48.
Score: 0.160
-
Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysis. BMJ. 2019 Oct 10; 367:l5476.
Score: 0.144
-
Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial. Catheter Cardiovasc Interv. 2010 May 01; 75(6):928-35.
Score: 0.075
-
Pharmacoinvasive management of acute coronary syndrome: incorporating the 2007 ACC/AHA guidelines: the CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report--III. J Invasive Cardiol. 2007 Dec; 19(12):525-38; quiz 539-40.
Score: 0.063
-
Strategies for optimizing outcomes in the NSTE-ACS patient The CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report. J Invasive Cardiol. 2006 Dec; 18(12):617-39.
Score: 0.059
-
The role of percutaneous revascularization in the treatment of ischemic heart disease: insights from published reports and randomized clinical trials. Chest. 1997 Sep; 112(3):805-21.
Score: 0.031
-
Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: results from SYNERGY. Int J Cardiol. 2010 Sep 24; 144(1):36-41.
Score: 0.018